Table 3.

Treatment agents used in the included studies.

	Treatment	Agents	Number of studies	n/N*	%
Pharmacologic treatment	Antiviral drugs	Lopinavir	6	9/9	100
		Arbidol hydrochloride	2	6/6	100
		Oseltamivir	5	1/1	100
		Veletonavir	1	1/1	100
		Remdesivir	1	1/1	100
		Ribavirin	1	1/1	100
		Ritonavir	1	1/1	100
		Gancyclovir	1	1/1	100
	Antibacterial drugs	Moxifloxacin	4	5/5	100
		Vancomycin	1	1/1	100
		Cefepime	1	1/1	100
		Meropenem	2	2/2	100
		Piperacillin tazobactam	2	2/2	100
		Sefoselis	1	1/1	100
		Linezolid	1	1/1	100
		Levofloxacin	1	1/2	50
	Others	Methylprednisolone	5	6/6	100
		Ambroxol Hydrochloride	1	1/1	100
		Acetaminophen	2	2/2	100
		Ibuprofen	2	2/2	100
		Intravenous Immunoglobulin	3	4/7	57
		Guaifenesin	1	1/1	100
		Ondansetron	1	1/1	100
		Interferon alpha-2b	2	2/2	100
		Herbal patent medicine	2	3/3	100
Non-pharmacologic treatment	Oxygen therapy	Non-invasive	6	10/10	100

^*n, number of patients under treatment; N, the total number of patients with COVID-19.